Scott Fields

About the Author Scott Fields

A media and finance professional with four years experience at Australia’s largest business newspaper: As a journalist, I have covered major economic and financial events, in depth and in a timely manner, building strong relationships with senior executive. I am twice the recipient of Citigroup’s Journalism Award for Excellence in Financial Markets coverage. Prior to my current role I held the role of senior editor at a capital markets publication and worked on the bond syndicate desk at a major bank.

2015 Will Be A Difficult Year For LNDC But It Remains Attractive, Says Roth Capital

In a research report issued today, Roth Capital analyst Anton Brenner reiterated a Buy rating on Landec (NASDAQ:LNDC) with a $18 price target, …

Roth Capital Assigns Buy On Masimo Following Patent Victory

In a research report released Friday, Roth Capital analyst Chris Lewis assigned a Buy rating on Masimo Corp. (NASDAQ:MASI) with a $29 price target, following …

PowerSecure: We Would Be Buyers On Recent Weakness, Says Roth Capital

In a research report issued yesterday, Roth Capital analyst Matt Koranda assigned a Buy rating on PowerSecure International (NYSE:POWR) with a price target …

Neptune: Phase 2 Topline Win Welcomes Neptune Into Prescription Omega-3 League, Says H.C. Wainwright

In a research report released Friday, analyst Andrew Fein of H.C.

Maxim Assigns Buy On Keryx Following Issuance Of Additional Patent On Ferric Citrate

In a research note published today, Maxim Group analyst Jason Kolbert assigned a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) with a $26 price target, as …

Brean Capital Comments On Keryx Following Issuance Of A New U.S. Patent

In a research note published today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) with a $26 price target, as the …

Oppenheimer Highlights Takeaways From Cisco’s Investor Event

In a research note issued today, Oppenheimer analyst Ittai Kidron maintained an Outperform rating on Cisco (NASDAQ:CSCO) with a $27 price target, following an investor event …

Oppenheimer Maintains Bullish Stance On Zogenix Following sNDA Filling For Abuse Deterrent Zohydro Formulation

In a research note published today, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a $2.50 price target, as the …

Oppenheimer Reiterates Outperform On Igi Laboratories On The Heels Of A New Deal With Valeant

In a research report today, Oppenheimer analyst Rohit Vanjani reiterated an Outperform rating on Igi Laboratories (NYSE:IG) with a $10 price target, following product acquisition …

Craft Brew Alliance: Roth Capital Analyst Provides Key Points From Investor Meetings

In a research report published Wednesday, Roth Capital analyst Anton Brenner assigned a Buy rating on Craft Brewers Alliance Inc (NASDAQ:BREW) with a $19 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts